Stockscreener 앱 받기
10.21
2.30%
-0.24
시간 외 거래:
11.11
0.90
+8.81%
전일 마감가:
$10.45
열려 있는:
$10.7
하루 거래량:
2,184
Relative Volume:
0.46
시가총액:
$59.61M
수익:
$503.40K
순이익/손실:
$9.17M
주가수익비율:
5.6381
EPS:
1.8109
순현금흐름:
$-604.40K
1주 성능:
-6.38%
1개월 성능:
+1.86%
6개월 성능:
-19.73%
1년 성능:
+0.65%
1일 변동 폭
$10.21
$10.70
1주일 범위
$10.21
$11.09
52주 변동 폭
$8.56
$14.76
Daxor Corporation Stock (DXR) Company Profile
명칭
Daxor Corporation
전화
212-330-8500
주소
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.21 | 61.01M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-05-16 | 개시 | Ascendiant Capital Markets | Buy |
Daxor Corporation 주식(DXR)의 최신 뉴스
DXR|Daxor Corp|Price:10.450|Chg%:+0.340 - TradingKey
Daxor Corp (DXR) Balance Sheet - TradingKey
Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Daxor Corp (DXR) Institutional Confidence - TradingKey
Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daxor (DXR) Proxy filing Summary - Quartr
Understanding Momentum Shifts in (DXR) - Stock Traders Daily
Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Nigeria
Daxor to exhibit blood volume analyzer at dysautonomia conference - Investing.com
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - The Manila Times
Daxor Corporation Announces First-Time Exhibition at the - GlobeNewswire
Daxor debuts Blood Volume Analyzer at dysautonomia conference - Stock Titan
DXR Q3 2007 Earnings: EPS Surges 326% Above Estimates, Stock Climbs $1.44Earnings Miss Alert - DonanımHaber
DXRDaxor Corp Options - Finviz
DXR Q3 2007 Earnings: Massive EPS Surprise of 325.7% on Reported Earnings of $0.43Quarterly Earnings - DonanımHaber
Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily
Daxor Corporation (DXR) Edges Higher, Testing Key Resistance ZoneAdvance Decline Volume - dars.gov.et
Enterprise value to EBITDA forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – FWB:DX5 - TradingView
Price to book forward of Daxor Corporation – FWB:DX5 - TradingView
Enterprise value to revenue forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBIT forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to earnings forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBITDA forward of Daxor Corporation – FWB:DX5 - TradingView
Daxor Corporation (DXR) Edges Lower, Testing Support Levels Near $10.25Market Profile - dars.gov.et
DX5 Forecast — Price Target — Prediction for 2027 - TradingView
Daxor Corporation Actuals & Estimates (NASDAQ:DXR) - TradingView
DXR Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Daxor Corp For: 25 June By Investing.com - Investing.com South Africa
Daxor (DXR) CFO receives 12,000-share stock grant, now holds 33,050 - Stock Titan
DAXOR (DXR) CEO receives 30,000-share equity grant, now holds 243,694 - Stock Titan
Daxor (DXR) Chief Scientific Officer receives 25,000-share stock grant - Stock Titan
Daxor (DXR) director granted 2,500 stock options at $10.14 - Stock Titan
Daxor (DXR) director awarded 2,500 stock options at $10.14 strike - Stock Titan
DAXOR CORP (DXR) director receives 2,500 stock options at $10.14 strike - Stock Titan
DAXOR (DXR) director awarded 2,500 stock options at $10.14 strike price - Stock Titan
Daxor Shareholders Reelect Board and Ratify Auditor - The Globe and Mail
Daxor Corporation 8-K Filing June 2026: Shareholder Vote Results, Nasdaq Listing, and Company Details - Minichart
Daxor (NASDAQ: DXR) investors reelect full board and ratify Bush & Associates as auditor - Stock Titan
Number of shareholders of Daxor Corporation – BOATS:DXR - TradingView
Daxor Corporation (DXR) Holds Near Support After Modest DeclineSentiment Divergence - dars.gov.et
Discipline and Rules-Based Execution in DXR Response - Stock Traders Daily
Daxor (DXR) Proxy Filing Summary - Quartr
Daxor (DXR) Q4 2025 earnings summary - Quartr
Daxor (DXR) Q2 2024 earnings summary - Quartr
Daxor (DXR) Corporate Presentation Summary - Quartr
Daxor (DXR) Q4 2024 earnings summary - Quartr
Daxor Corporation (DXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
0.03%
자본화:
|
볼륨(24시간):